Nordic Health Registers

Home/Nordic Health Registers

New study: Many patients go for years without seeing a sclerosis doctor

2018-09-28T14:14:20+01:00April 6th, 2018|Categories: Diseases of the nervous system, Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Six out of ten of the sclerosis patients who are not in disease-modifying treatment do not attend annual follow-ups. This means that the patients do not receive the symptom management or rehabilitation they need. These results come from a new study by ApHER conducted in collaboration with the Danish Multiple Sclerosis Society, presented by Prof. Anders Green [...]

It is a good investment to prevent the development of lifestyle diseases such as diabetes

2018-09-28T13:44:19+01:00March 31st, 2018|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

A poorly regulated diabetes patient is costly for both the public healthcare system and the private insurance companies. In a recent cost-effectiveness study of the LIVA platform ApHER concludes that there is a desirable investment return by managing diabetes patients digitally through online lifestyle coaching. Read the article at LIVA Healthcare here.

Register studies of diabetes treatment arouse method discussions

2018-08-03T15:25:19+01:00September 25th, 2017|Categories: Endocrine, nutritional and metabolic diseases, Nordic Health Registers|

Randomized studies of SLGT-2 inhibitors and GLP-1 receptor agonists are now followed-up by register studies. And scientists are eagerly presenting real life data these years. This makes professor Anders Green to point out that scientists need to remember openness towards each others' methodological schools. Read the article from Medicinsk Tidsskrift here.

Danish register studies are in world class – but threatened

2018-08-03T15:25:53+01:00June 12th, 2017|Categories: Nordic Health Registers|

Denmark is a world champion in register studies which has also provided invaluable knowledge in diabetes research. However, legal back-and-forthing can cost us the leading place, experts warn. Read the article at Medicinsk Tidsskrift here.

Annual meeting of the Scandinavian Society for the study of diabetes

2018-08-03T15:26:33+01:00May 21st, 2017|Categories: Endocrine, nutritional and metabolic diseases, Nordic Health Registers, Pharmacoepidemiology|

Professor Anders Green gave an invited presentation on the epidemiological results from the Diabetes Impact Study in connection with the Annual Meeting of the Scandinavian Society for the Study of Diabetes, held the 19th-21st of May in Nyborg (Denmark).

Different patterns of Finasteride use in males with prostate hyperplasia across Nordic countries

2018-08-23T10:38:38+01:00February 22nd, 2016|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

The Nordic countries Denmark, Finland, Norway and Sweden have many cross-national similarities regarding political systems and universal tax-financed healthcare systems with full population coverage, but different utilization patterns of Finansteride have been observed in a new study. Link to publication.

The Diabetes Impact Study in the Danish media: Every 10th Dane will have Diabetes in 10 Years

2018-08-23T11:07:58+01:00October 27th, 2015|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

The newest publication of the Diabetes Impact Study reveals the dramatic forecasts of the diabetes epidemic. Today, 380,000 Danes have diabetes and this number will increase to 650,000 in 2015 and further 1.2 million people in 2040 according to the forecasts. The costs of diabetes in Denmark amounts up to almost 32 billion DKK every year, [...]

Prensentation of Diabetes Impact Study Results on August 20th 2015

2018-08-23T11:13:49+01:00August 20th, 2015|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

On August 20th 2015, APEHR presented the results of the Diabetes Impact Study 2013 together with the Danish Diabetes Association at a press conference. Among other interesting findings, the study showed that the diabetes-related costs of type 1 and type 2 diabetes in Denmark were 31.8 billion DKK/4.8 billion EUR in 2011, furthermore, the attributable costs [...]

The Diabetes Impact Study: Incidence, morbidity, mortality, and prevalence of diabetes in Denmark

2018-08-23T14:04:40+01:00July 23rd, 2015|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

In cooperation wih the University of Southern Denmark, APEHR has just published an article as part of the Danish Diabetes Impact Study 2013, where we present trends in the incidence, morbidity, mortality, and prevalence of diabetes in Denmark for the period 2000 through 2011. Link to publication.

Real World Evidence: Clinical evidence – from the real world

2018-08-23T11:42:41+01:00January 20th, 2015|Categories: Cancer, Nordic Health Registers|

With the Danish parliament in front, Denmark is preparing on becoming the internationally leading country in register- and database research within the health field. Professor and epidemiological scientist, Anders Green, is one of the architects behind the standardized platform on the future clinical cancer databases and tells his perspective on new ways within cancer treatment in Magasinet [...]